Publicacións en colaboración con investigadores/as de GlaxoSmithKline (Spain) (11)

2021

  1. Correction to: REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study (Drugs, (2021), 81, 15, (1763-1774), 10.1007/s40265-021-01597-9)

    Drugs

  2. Cost-effectiveness analysis of anti–IL-5 therapies of severe eosinophilic asthma in Spain

    Journal of Medical Economics, Vol. 24, Núm. 1, pp. 874-882

  3. REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study

    Drugs, Vol. 81, Núm. 15, pp. 1763-1774

2010

  1. Antimicrobial resistance among respiratory pathogens in Spain: Latest data and changes over 11 years (1996-1997 to 2006-2007)

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 7, pp. 2953-2959

2005

  1. Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 5, pp. 1965-1972

2003

  1. Differences in Co-Resistance to Ciprofloxacin and Penicillin Depending upon the Phenotype of Erythromycin Resistance in Streptococcus pneumoniae

    Journal of Chemotherapy, Vol. 15, Núm. 5, pp. 512-514

  2. Evolution of penicillin and erythromycin co-resistance in Streptococcus pneumoniae in Spain

    International Journal of Antimicrobial Agents, Vol. 22, Núm. 5, pp. 541-544

2002

  1. Activities of six different quinolones against clinical respiratory isolates of streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 46, Núm. 8, pp. 2665-2667

  2. Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin [3]

    Journal of Antimicrobial Chemotherapy

2001

  1. Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999

    Antimicrobial Agents and Chemotherapy, Vol. 45, Núm. 11, pp. 3226-3228

2000

  1. Phenotypic testing predicts virological response in successive protease inhibitor-based regimens

    AIDS, Vol. 14, Núm. 9